PharmaShots | Incisive News in 3 Shots

Subscribe Now

ovartis

Novartis Reports the US FDA’s Accelerated Approval of Fabhalta to Treat Primary IgA Nephropathy (IgAN)

Novartis Reports the US FDA’s Accelerated Approval of Fabhalta to Treat Primary IgA Nephropathy (IgAN)

August 9, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us